Data/hora: 03/06/2024 15:10:09

Provedor de dados: 	Anais da Academia Brasileira de Ciências	
País: 	Brazil	
Título: 	2,3,8-Trisubstituted Quinolines with Antimalarial Activity	
Autores: 	MARTINEZ,PABLO D.G.; KRAKE,SUSANN H.; POGGI,MAITIA L.; CAMPBELL,SIMON F.; WILLIS,PAUL A.; DIAS,LUIZ C.	
Data: 	2018-01-01	
Ano: 	2018	
Palavras-chave: 	Antimalarial activity; Trisubstituted quinoline; SAR; Resistance.	
Resumo: 	ABSTRACT Combination therapy drugs are considered a fundamental way to control malaria as it mimimizes the risk of emergence of resistance to the individual partner drugs. Consequently, this type of therapy constitutes a driving force for the discovery of new drugs with different modes of action, since this will provide options for combining different drugs to achieve the optimum antimalarial treatment. In this context, a 2,3,8-trisubstitued quinoline compound was found in a high throughput screen (HTS) to show an excellent inhibition of P. falciparum NF54 (IC50 = 22 nM) and low cytotoxicity. We performed a detailed evaluation of the substituents to improve the metabolic stability and solubility liabilities of the original hit and identified derivatives with enhanced physicochemical and/or PK properties and that maintained biological activity. However the high potency was not retained on testing against drug resistant plasmodium strains.	
Tipo: 	Info:eu-repo/semantics/article	
Idioma: 	Inglês	
Identificador: 	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652018000301215	
Editor: 	Academia Brasileira de Ciências	
Relação: 	10.1590/0001-3765201820170820	
Formato: 	text/html	
Fonte: 	Anais da Academia Brasileira de Ciências  v.90 n.1 suppl.2 2018	
Fonte: 	info:eu-repo/semantics/openAccess